ABT Financial Facts
Research and development: 352MDilutive Common Stock Options and Awards (in shares): 0
See Full Income Statement
Intangible Assets, net of amortization: 4.67B
Total Shareholders' Investment: 20.9B
See Full Balance Sheet
Abbott Labs (ABT) Earnings
|
Expand Research on ABT
| Next EPS Date | 7/18/24 *Est. | EPS Growth Rate | -4.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +2.1% | Revenue Growth Rate | +2.2% *Last Qtr. |
| Average % Move 1-Wk after EPS | +1.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/20/22 |  |
Q122 | $1.73 | $1.47 | +$0.26 | $11.9B | $11.02B | = |  | | Details |
| 1/26/22 | |
Q421 | $1.32 | $1.19 | +$0.13 | $11.5B | $10.58B | = | | | Details |
| 7/20/22 | |
Q222 | $1.43 | $1.13 | +$0.30 | $11.3B | $10.31B | = | | | Details |
| 10/20/21 | |
Q321 | $1.40 | $0.93 | +$0.47 | $10.9B | $9.44B | = | | | Details |
1/23/13  |
|
Q412 | $1.51 | $1.50 | +$0.01 | $10.8B | $10.58B | = | | | Details |
| 1/27/21 | |
Q121 | $1.45 | $1.35 | +$0.10 | $10.7B | $9.94B | = | | | Details |
| 4/20/21 | |
Q221 | $1.32 | $1.27 | +$0.05 | $10.5B | $10.69B | = | | | Details |
| 10/19/22 | Q322 | $1.15 | $0.95 | +$0.20 | $10.4B | $9.63B | = | | | Details |
